share_log

Marpai | 8-K: Current report

SEC announcement ·  Jan 17 13:00
Summary by Futu AI
On January 16, 2024, Marpai Inc., a health technology company, announced the entry into a Securities Purchase Agreement with key insiders, including entities controlled by CEO Damien Lamendola, Chairman Yaron Eitan, and director Robert Pons. The agreement involves the private placement sale of 1,322,100 shares of Marpai's Class A common stock at a price of $0.9201 per share, equivalent to the consolidated closing bid price on Nasdaq for that date. The transaction is exempt from registration under the Securities Act of 1933, according to Section 4(a)(2) and Rule 506(b) of Regulation D, meaning the shares cannot be sold in the U.S. without registration or an exemption. The details of the Securities Purchase Agreement are disclosed in the company's Form 8-K filed with the SEC and are further detailed in Exhibit 10.1 attached to the report.
On January 16, 2024, Marpai Inc., a health technology company, announced the entry into a Securities Purchase Agreement with key insiders, including entities controlled by CEO Damien Lamendola, Chairman Yaron Eitan, and director Robert Pons. The agreement involves the private placement sale of 1,322,100 shares of Marpai's Class A common stock at a price of $0.9201 per share, equivalent to the consolidated closing bid price on Nasdaq for that date. The transaction is exempt from registration under the Securities Act of 1933, according to Section 4(a)(2) and Rule 506(b) of Regulation D, meaning the shares cannot be sold in the U.S. without registration or an exemption. The details of the Securities Purchase Agreement are disclosed in the company's Form 8-K filed with the SEC and are further detailed in Exhibit 10.1 attached to the report.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.